EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Core Viewpoint - Ten former employees of MiMedx Group, Inc. have filed counterclaims against the company, alleging that MiMedx engaged in fraudulent practices to exploit Medicare and pressured employees to sell products without FDA approval [1][2]. Group 1: Allegations Against MiMedx - The counterclaims assert that MiMedx pressured healthcare providers to use medically unnecessary products on vulnerable patients, including wounded veterans and diabetics [2]. - Allegations include that MiMedx incentivized fraud against the U.S. government, particularly Medicare, through predatory sales practices [2]. - The claims reference a warning letter from the FDA regarding MiMedx's AXIOFILL product, indicating that the company misled its sales team about the product's marketability [2][3]. Group 2: Employee Experience and Company Response - Former employees claim they were compelled to sell a product that the FDA determined could not be marketed without prior approval, leading to their departure from the company [3]. - The counterclaims describe the original lawsuit from MiMedx as an intimidation tactic against employees who left due to the company's alleged misconduct [1].